Plasminogen activator inhibitor 1 activity and other coronary risk factors

Area of Science:

• Cardiovascular Disease Research
• Biochemistry
• Medical Science

Background:

• Plasma plasminogen activator inhibitor 1 (PAI-1) is implicated in cardiovascular health.
• The specific coronary risk factors associated with PAI-1 activity require further investigation.
• Understanding these associations is crucial for managing cardiovascular risk.

Purpose of the Study:

• To examine the association between 27 coronary risk factors and plasma PAI-1 activity.
• To compare these associations in healthy individuals and myocardial infarction survivors.
• To identify distinct risk factor profiles for PAI-1 activity in different populations.

Main Methods:

• Cross-sectional study design.
• Inclusion of 24 healthy controls and 22 myocardial infarction survivors.
• Analysis of 27 coronary risk factors including age, anthropometrics (intraabdominal fat), and biochemical analytes (triglyceride, von Willebrand factor).
• Univariate and multiple linear regression analyses were employed.

Main Results:

• In healthy controls, triglyceride and von Willebrand factor were significantly associated with PAI-1 activity (p=0.0002, R(2)=0.55).
• In myocardial infarction survivors, age and intraabdominal adipose tissue were significantly associated with PAI-1 (p=0.0011, R(2)=0.51).
• Coronary risk factors explained over 50% of PAI-1 activity variation in both groups.

Conclusions:

• Healthy individuals and myocardial infarction survivors exhibit different coronary risk factors associated with PAI-1 activity.
• These findings highlight population-specific relationships between risk factors and PAI-1.
• Further research may elucidate targeted interventions based on these distinct associations.